These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. Perani D; Garibotto V; Gorini A; Moresco RM; Henin M; Panzacchi A; Matarrese M; Carpinelli A; Bellodi L; Fazio F Neuroimage; 2008 Aug; 42(1):306-14. PubMed ID: 18511303 [TBL] [Abstract][Full Text] [Related]
4. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Adams KH; Pinborg LH; Svarer C; Hasselbalch SG; Holm S; Haugbøl S; Madsen K; Frøkjaer V; Martiny L; Paulson OB; Knudsen GM Neuroimage; 2004 Mar; 21(3):1105-13. PubMed ID: 15006678 [TBL] [Abstract][Full Text] [Related]
5. Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder. Olver JS; O'Keefe G; Jones GR; Burrows GD; Tochon-Danguy HJ; Ackermann U; Scott A; Norman TR J Affect Disord; 2009 Apr; 114(1-3):321-6. PubMed ID: 18706700 [TBL] [Abstract][Full Text] [Related]
7. Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907. Simpson HB; Slifstein M; Bender J; Xu X; Hackett E; Maher MJ; Abi-Dargham A Biol Psychiatry; 2011 Nov; 70(9):897-904. PubMed ID: 21855857 [TBL] [Abstract][Full Text] [Related]
8. A PET [18F]altanserin study of 5-HT2A receptor binding in the human brain and responses to painful heat stimulation. Kupers R; Frokjaer VG; Naert A; Christensen R; Budtz-Joergensen E; Kehlet H; Knudsen GM Neuroimage; 2009 Feb; 44(3):1001-7. PubMed ID: 19007894 [TBL] [Abstract][Full Text] [Related]
9. Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study. Kim E; Howes OD; Park JW; Kim SN; Shin SA; Kim BH; Turkheimer FE; Lee YS; Kwon JS Psychol Med; 2016 Jan; 46(2):357-66. PubMed ID: 26423910 [TBL] [Abstract][Full Text] [Related]
10. Brain regional α-[11C]methyl-L-tryptophan trapping in medication-free patients with obsessive-compulsive disorder. Berney A; Leyton M; Gravel P; Sibon I; Sookman D; Rosa Neto P; Diksic M; Nakai A; Pinard G; Todorov C; Okazawa H; Blier P; Nordahl TE; Benkelfat C Arch Gen Psychiatry; 2011 Jul; 68(7):732-41. PubMed ID: 21383250 [TBL] [Abstract][Full Text] [Related]
11. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin. Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490 [TBL] [Abstract][Full Text] [Related]
12. Caudate gray matter volume in obsessive-compulsive disorder is influenced by adverse childhood experiences and ongoing drug treatment. Benedetti F; Poletti S; Radaelli D; Pozzi E; Giacosa C; Ruffini C; Falini A; Smeraldi E J Clin Psychopharmacol; 2012 Aug; 32(4):544-7. PubMed ID: 22722505 [TBL] [Abstract][Full Text] [Related]
13. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET. Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031 [TBL] [Abstract][Full Text] [Related]
14. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans. Erritzoe D; Holst K; Frokjaer VG; Licht CL; Kalbitzer J; Nielsen FA; Svarer C; Madsen J; Knudsen G J Neurosci; 2010 Mar; 30(9):3391-7. PubMed ID: 20203198 [TBL] [Abstract][Full Text] [Related]
15. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment: Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183 [TBL] [Abstract][Full Text] [Related]
16. Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness. Bailer UF; Price JC; Meltzer CC; Mathis CA; Frank GK; Weissfeld L; McConaha CW; Henry SE; Brooks-Achenbach S; Barbarich NC; Kaye WH Neuropsychopharmacology; 2004 Jun; 29(6):1143-55. PubMed ID: 15054474 [TBL] [Abstract][Full Text] [Related]